Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-blocker Stratification Using Quantitative MRI Techniques to Assess Portal Pressure and Response to Treatment in Patients With Portal Hypertension

NCT03114813 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT03114813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03114813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-blocker Stratification Using Quantitative MRI Techniques to Assess Portal Pressure and Response to Treatment in Patients With Portal Hypertension
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
January 31, 2024
Enrollment
68 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, portal hypertension, varix, esophageal